Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment. [PDF]
Asbell P+7 more
europepmc +1 more source
Molecular characterization of atopic dermatitis:a meta-analysis [PDF]
Ewald, David Adrian
core
Dupilumab treatment has no effect on the nasal microbiome in patients with NSAID-exacerbated respiratory disease: a longitudinal pilot study. [PDF]
Bartosik T+12 more
europepmc +1 more source
Clinical Effectiveness, Clinical Stability, and Effects on Serum Galectin-7 Levels of Dupilumab and JAK Inhibitors in Moderate-to-Severe Atopic Dermatitis: A Real-World, Single-Center Analysis. [PDF]
Horie A+9 more
europepmc +1 more source
Rapid Itch Improvement and Skin Clearance with Upadacitinib Versus Placebo (Measure Up 1 and Measure Up 2) and Versus Dupilumab (Heads Up): Results from Three Phase 3 Clinical Trials in Patients with Moderate-to-Severe Atopic Dermatitis. [PDF]
Simpson EL+14 more
europepmc +1 more source
Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab? [PDF]
Sebastian N+5 more
europepmc +1 more source
Leukocytoclastic Vasculitis With Eosinophilia in a Patient Receiving Dupilumab Therapy. [PDF]
Wandler AM, Joseph JM, Haas C.
europepmc +1 more source
Real-world Experience with JAK Inhibitors and Dupilumab in Dystrophic Epidermolysis Bullosa: A Case Report and Literature Review. [PDF]
Ling S, Dou X.
europepmc +1 more source
Efficacy and Safety of Dupilumab vs Narrowband UVB for the Treatment of Chronic Hand Dermatitis: A Retrospective Study. [PDF]
Branyiczky MK+4 more
europepmc +1 more source
Time to Disease Control with Dupilumab for Bullous Pemphigoid: A Systematic Review and Meta-analysis. [PDF]
Mainville L+4 more
europepmc +1 more source